<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Myomo Inc. — News on 6ix</title>
<link>https://6ix.com/company/myomo-inc</link>
<description>Latest news and press releases for Myomo Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 20 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/myomo-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d76ed351cc36e47533d4d9.webp</url>
<title>Myomo Inc.</title>
<link>https://6ix.com/company/myomo-inc</link>
</image>
<item>
<title>Myomo Introduces Myomo Mobile App to Enhance Clinical Workflow and Patient Engagement</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-introduces-myomo-mobile-app-to-enhance-clinical-workflow-and-patient-engagement</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-introduces-myomo-mobile-app-to-enhance-clinical-workflow-and-patient-engagement</guid>
<pubDate>Mon, 20 Apr 2026 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 20, 2026--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for people with neurological disorders and upper-limb paralysis, announces the launch of the Myomo® Mobile App, a new digital tool designed to support clinicians and patients throughout the MyoPro® experience.</description>
</item>
<item>
<title>Myomo Appoints William J Febbo to its Board of Directors</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-appoints-william-j-febbo-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-appoints-william-j-febbo-to-its-board-of-directors</guid>
<pubDate>Thu, 16 Apr 2026 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 16, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William "Will" Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of stockholders. With this appointment, Myomo has six directors.</description>
</item>
<item>
<title>Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results-4</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-reports-fourth-quarter-and-full-year-2025-financial-and-operating-results-4</guid>
<pubDate>Mon, 09 Mar 2026 20:06:00 GMT</pubDate>
<description>BURLINGTON, Mass., March 09, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months and year ended December 31, 2025.</description>
</item>
<item>
<title>Myomo and Elevance Health Agree to Contract for Multi-State Network Participation</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation-2</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-and-elevance-health-agree-to-contract-for-multi-state-network-participation-2</guid>
<pubDate>Mon, 09 Mar 2026 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., March 09, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effec</description>
</item>
<item>
<title>Myomo to Report Fourth Quarter 2025 Financial Results on March 9</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-report-fourth-quarter-2025-financial-results-on-march-9</guid>
<pubDate>Mon, 02 Mar 2026 21:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., March 02, 2026--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and year ended December 31, 2025 on Monday, March 9, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business updat</description>
</item>
<item>
<title>Myomo Reports Third Quarter 2025 Financial and Operating Results</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-reports-third-quarter-2025-financial-and-operating-results</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-reports-third-quarter-2025-financial-and-operating-results</guid>
<pubDate>Mon, 10 Nov 2025 21:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., November 10, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025.</description>
</item>
<item>
<title>Myomo to Report Third Quarter 2025 Financial Results on November 10</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-report-third-quarter-2025-financial-results-on-november-10</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-report-third-quarter-2025-financial-results-on-november-10</guid>
<pubDate>Mon, 03 Nov 2025 21:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., November 03, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questi</description>
</item>
<item>
<title>Myomo to Present at the H.C. Wainwright 27th Annual Global Investment Conference</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-present-at-the-hc-wainwright-27th-annual-global-investment-conference</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-present-at-the-hc-wainwright-27th-annual-global-investment-conference</guid>
<pubDate>Tue, 02 Sep 2025 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., September 02, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, president and chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palac</description>
</item>
<item>
<title>Myomo Reports Second Quarter 2025 Financial and Operating Results</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-reports-second-quarter-2025-financial-and-operating-results</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-reports-second-quarter-2025-financial-and-operating-results</guid>
<pubDate>Mon, 11 Aug 2025 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., August 11, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2025.</description>
</item>
<item>
<title>Myomo to Report Second Quarter 2025 Financial Results on August 11</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-report-second-quarter-2025-financial-results-on-august-11</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-report-second-quarter-2025-financial-results-on-august-11</guid>
<pubDate>Mon, 04 Aug 2025 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., August 04, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter of 2025 on Monday, August 11, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions</description>
</item>
<item>
<title>Myomo Provides Highlights of Today’s Investor & Analyst Day Event</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-provides-highlights-of-todays-investor-and-analyst-day-event</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-provides-highlights-of-todays-investor-and-analyst-day-event</guid>
<pubDate>Wed, 18 Jun 2025 12:30:00 GMT</pubDate>
<description>BURLINGTON, Mass., June 18, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, will host an Investor & Analyst Day event today from 10 a.m. to 3 p.m. Eastern time during which management will provide an in-depth review of the Company’s business model, provide a tour of its new headquarters and manufacturing facility and discuss long-ran</description>
</item>
<item>
<title>Myomo Reports First Quarter 2025 Financial and Operating Results</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-reports-first-quarter-2025-financial-and-operating-results</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-reports-first-quarter-2025-financial-and-operating-results</guid>
<pubDate>Wed, 07 May 2025 21:11:00 GMT</pubDate>
<description>BURLINGTON, Mass., May 07, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.</description>
</item>
<item>
<title>Myomo to Host Investor & Analyst Day Event on June 18, 2025</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-host-investor-and-analyst-day-event-on-june-18-2025</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-host-investor-and-analyst-day-event-on-june-18-2025</guid>
<pubDate>Thu, 01 May 2025 12:30:00 GMT</pubDate>
<description>BURLINGTON, Mass., May 01, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces the Company will be hosting its first-ever Investor & Analyst Day event on Wednesday, June 18, 2025. The event will take place at Myomo’s new corporate headquarters and manufacturing facility in Burlington, Mass., and will offer an in-depth look at t</description>
</item>
<item>
<title>Myomo to Report First Quarter 2025 Financial Results on May 7</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-to-report-first-quarter-2025-financial-results-on-may-7</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-to-report-first-quarter-2025-financial-results-on-may-7</guid>
<pubDate>Wed, 30 Apr 2025 20:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 30, 2025--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025.</description>
</item>
<item>
<title>Myomo Launches the MyoPro® 2x</title>
<link>https://6ix.com/company/myomo-inc/news/myomo-launches-the-myopror-2x</link>
<guid isPermaLink="true">https://6ix.com/company/myomo-inc/news/myomo-launches-the-myopror-2x</guid>
<pubDate>Wed, 30 Apr 2025 12:05:00 GMT</pubDate>
<description>BURLINGTON, Mass., April 30, 2025--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular conditions, today announced the launch of the MyoPro 2x, the latest evolution in its flagship MyoPro product line.</description>
</item>
</channel>
</rss>